Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 1, 1997 CD
Six back issues from 1997 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 1 No. 1 January/February 1997 Hospice Care
Vol. 1 No. 2 March/April 1997 Pediatric Care
Vol. 1 No. 3 May/June 1997 Geriatric Care
Vol. 1 No. 4 July/August 1997 Compounding for Animals
Vol. 1 No. 5 September/October 1997 Home Health Care
Vol. 1 No. 6 November/December 1997 Diverse Ambulatory Patients

Volume 1, 1997 CD ARTICLES

Volume1, 1997 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Hospice Care and the Pharmacist Vol. 1 No. 1 11
Rectal and Stomal Administration of Analgesic Suppositories Vol. 1 No. 1 12
Omeprazole (Prilosec) in the Atypical Patient, Administration of Vol. 1 No. 1 13
The Ten Basic Steps in Filling a Prescription: Then and Now Vol. 1 No. 1 14
Aromatherapy and the Hospice Patient Vol. 1 No. 1 18
Aromatherapy Mood Elevation No. 1 Vol. 1 No. 1 20
Aromatherapy Mood Elevation No. 2 Vol. 1 No. 1 21
An Ancient Heritage Beckons Pharmacists Vol. 1 No. 1 22
ABH Hard Troche Vol. 1 No. 1 26
ABH Soft Troche Vol. 1 No. 1 27
ABH Sugar Troche Vol. 1 No. 1 27
Antiemetic Suppositories of the Gralla Type Vol. 1 No. 1 28
HDDM Hard Troche Vol. 1 No. 1 29
HDDM Soft Troche Vol. 1 No. 1 30
HDDM Sugar Troche Vol. 1 No. 1 30
Metoclophen Nausea Suppositories Vol. 1 No. 1 31
Metoclophen-Modified Nausea Suppositories Vol. 1 No. 1 31
Morphine Sulfate Slow-Release Suppositories Vol. 1 No. 1 32
Ondansetron HCl Suppositories Vol. 1 No. 1 34
Morphine Suppositories Vol. 1 No. 1 36
Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution Vol. 1 No. 1 37
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Vol. 1 No. 1 38
Suppository Displacement Factor Vol. 1 No. 1 39
Rule of Sixes for Filling Hard-Shell Gelatin Capsules, Rule Vol. 1 No. 1 40
Electronic Balance Maintenance/Calibration Vol. 1 No. 1 45
General Guidelines for Use of Chemicals for Prescription Compounding Vol. 1 No. 1 46
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Vol. 1 No. 1 49
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures Vol. 1 No. 1 54
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup compounded from commercial tablets Vol. 1 No. 1 60
PostScription: The 90s Pharmacist Vol. 1 No. 1 64
The Decision to Compound Vol. 1 No. 2 71
The Compounding Pharmacist Vol. 1 No. 2 73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Vol. 1 No. 2 75
The Mortar and Pestle Vol. 1 No. 2 80
Compounding for the Pediatric Patient Vol. 1 No. 2 84
Attention Deficit Hyperactivity Disorder Vol. 1 No. 2 87
Flavors and Flavoring Vol. 1 No. 2 90
Compounded Suppositories and Pharmaceutical Care Vol. 1 No. 2 93
Acetazolamide 25-mg/mL Oral Liquid Vol. 1 No. 2 101
Azathioprine 50-mg/mL Oral Liquid Vol. 1 No. 2 102
Flecainide Acetate 20-mg/mL Oral Liquid Vol. 1 No. 2 103
Methylcellulose 1% to 5% Solutions Vol. 1 No. 2 104
Methylcellulose Oral-Liquid Vehicles Vol. 1 No. 2 105
Pediatric Chewable Gummy Gel Base Vol. 1 No. 2 106
Pediatric Chocolate Troche Base Vol. 1 No. 2 106
Pediatric Chewable Gummy Gels Vol. 1 No. 2 107
Pediatric Chocolate Troche Vol. 1 No. 2 108
Nystatin Popsicles Vol. 1 No. 2 109
Procainamide HCl 50-mg/mL Oral Liquid Vol. 1 No. 2 110
Syrup NF Vol. 1 No. 2 111
Tetracaine 20-mg Lollipops Vol. 1 No. 2 112
Tetracycline Compound Troche Vol. 1 No. 2 113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Vol. 1 No. 2 114
Methylcellulose, Featured Excipient: Vol. 1 No. 2 115
Use, Standardization, Care of a pH Meter Vol. 1 No. 2 116
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Vol. 1 No. 2 118
The Compatibility of Common Respiratory Therapy Drug Combinations Vol. 1 No. 2 121
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs Vol. 1 No. 2 123
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture Vol. 1 No. 2 125
Stability of Allopurinol Suspension Compounded from Tablets Vol. 1 No. 2 128
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 2 132
PostScription: Growing the Tree of Pharmacy Vol. 1 No. 2 136
The Changing Body Vol. 1 No. 3 144
Creative Compounding for the Geriatric Patient Vol. 1 No. 3 147
Drug Products and Drug Packaging for the Elderly Vol. 1 No. 3 150
Common Diseases of the Elderly Vol. 1 No. 3 152
Building a Compounding Lab: Remodeling an Existing Facility or Starting from Scratch? Vol. 1 No. 3 156
Patient Handouts Vol. 1 No. 3 160
Computer Technology in the Compounding Pharmacy, The Use of Vol. 1 No. 3 162
Parenteral Admixture Incompatibilities:An Introduction Vol. 1 No. 3 165
Physical Stability of Urea Topical Formulations Vol. 1 No. 3 168
Allopurinol 20-mg/mL Oral Liquid Vol. 1 No. 3 174
Antiemetic Injection for Cancer Chemotherapy Vol. 1 No. 3 175
Dipyridamole 10-mg/mL Oral Liquid Vol. 1 No. 3 176
Dry Skin and Massage Lotion Vol. 1 No. 3 177
Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir Vol. 1 No. 3 178
Labetalol HCl 40-mg/mL Oral Liquid Vol. 1 No. 3 179
Metoprolol Tartrate 10-mg/mL Oral Liquid Vol. 1 No. 3 180
Piroxicam 2% in an Alcoholic Gel Vol. 1 No. 3 181
Progesterone 100-mg in Peanut-Oil Capsules Vol. 1 No. 3 182
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Vol. 1 No. 3 183
Spironolactone 25-mg/mL Oral Liquid Vol. 1 No. 3 184
Triple Estrogen 2.5-mg in Oil Capsules Vol. 1 No. 3 185
Triple Estrogen 2.5-mg in Lactose Capsules Vol. 1 No. 3 186
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules Vol. 1 No. 3 187
Verapamil HCl 50-mg/mL Oral Liquid Vol. 1 No. 3 188
Poloxamer, Featured Excipient: Vol. 1 No. 3 190
Calculations Vol. 1 No. 3 191
The Rule of Seven Vol. 1 No. 3 191
Pipette Calibration Vol. 1 No. 3 192
The Formulation Development and Stability of Spironolactone Suspension Vol. 1 No. 3 195
The Formulation Development and Stability of Metronidazole Suspension Vol. 1 No. 3 200
Metronidazole 15-mg/mL Suspension Vol. 1 No. 3 202
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections Vol. 1 No. 3 206
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 3 208
PostScription: Fat Loss: Important in Disease Management Vol. 1 No. 3 212
What Makes Pharmacists Different? Vol. 1 No. 4 214
Veterinary Compounding: A Bird's Eye View Vol. 1 No. 4 222
Suggested Flavors for Veterinary Medications Vol. 1 No. 4 228
Animal Drug Delivery Systems Vol. 1 No. 4 229
Compounding for Animals: The AVMA Perspective Vol. 1 No. 4 230
Symposium on Veterinary Compounding: A Pivotal Meeting Vol. 1 No. 4 231
Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Vol. 1 No. 4 233
Marketing to Veterinarians - Field Notes Vol. 1 No. 4 236
Compounding for Degenerative Myelopathy in the German Shepherd Vol. 1 No. 4 241
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Vol. 1 No. 4 242
Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary Vol. 1 No. 4 243
Antique Pill Making Tools Vol. 1 No. 4 246
Antifungal for Animals Vol. 1 No. 4 250
Canine Antiperspirant with Chlorhexidine Vol. 1 No. 4 251
Canine Diarrhea Capsules Vol. 1 No. 4 252
Canine Eye Ulceration Drops Vol. 1 No. 4 253
Canine Glucose Enema 60% Vol. 1 No. 4 254
Canine Methylpyrazole Solution for Ethylene Glycol Poisoning Vol. 1 No. 4 255
Canine Psyllium Hydrophilic Balls Vol. 1 No. 4 256
Cyclosporine Ophthalmic Drops for Animals Vol. 1 No. 4 257
Hair Moisturizer/Conditioner for Horses and Other Animals Vol. 1 No. 4 258
Kennel Cough Inhalation Solutions (Concentrated) Vol. 1 No. 4 259
Phenolated Glycerin Otic Solution for Animals Vol. 1 No. 4 260
Potassium Bromide 500-mg/mL Oral Solution for Animals Vol. 1 No. 4 261
Silver Sulfadiazine 1% Otic Lotion for Animals Vol. 1 No. 4 262
Sterile Vehicle for Mastitis Preparation for Animals Vol. 1 No. 4 263
Sulfur and Peruvian Balsam Ointment for Mange/Ringworm for Animals Vol. 1 No. 4 264
Carbopols, Featured Excipient: Vol. 1 No. 4 265
Calculations Vol. 1 No. 4 267
Monitoring Air Temperature and Humidity Vol. 1 No. 4 268
Atropine Overdosage with a Suppository Formulation Containing Atropine Sulfate Vol. 1 No. 4 271
Development of Clonidine HCl Injections for Epidural and Intrathecal Administration Vol. 1 No. 4 274
Stability of Bethanechol Chloride Oral Liquid Dosage Forms Vol. 1 No. 4 278
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection Vol. 1 No. 4 280
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Vol. 1 No. 4 282
PostScription: Compounding: Our Heritage Vol. 1 No. 4 286
Home Infusion and Alternative-Site Health Care: The Big Picture Vol. 1 No. 5 294
Continued Growth Predicted for Home Infusion Market Vol. 1 No. 5 298
Drug Stability and Compatibility: Special Considerations for Home Health Care Vol. 1 No. 5 301
Ambulatory Infusion Pump Review Vol. 1 No. 5 306
The Future and the Pharmacy Technician Vol. 1 No. 5 310
Extemporaneous Compounding in the Hospital Pharmacy Vol. 1 No. 5 314
Acetylcysteine 10% Ophthalmic Solution Vol. 1 No. 5 320
Baclofen 10-mg/mL Oral Liquid Vol. 1 No. 5 321
Captopril 0.75-mg/mL Oral Liquid Vol. 1 No. 5 322
Diltiazem HCl 12-mg/mL Oral Suspension Vol. 1 No. 5 323
Doxorubicin HCl-Vincristine Sulfate Injection Vol. 1 No. 5 324
Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia Vol. 1 No. 5 325
Granisetron HCl-Dexamethasone Sodium Phosphate Injection Vol. 1 No. 5 326
Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections Vol. 1 No. 5 327
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Vol. 1 No. 5 328
Metolazone 1-mg/mL Oral Suspension Vol. 1 No. 5 329
Morphine Sulfate-Bupivacaine HCl Injection Vol. 1 No. 5 330
Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free) Vol. 1 No. 5 331
Ondansetron HCl-Dexamethasone Sodium Phosphate Injection Vol. 1 No. 5 332
Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection Vol. 1 No. 5 333
Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations) Vol. 1 No. 5 334
Tropicamide-Hydroxyamphetamine Hydrobromide Ophthalmic Solution Vol. 1 No. 5 335
Benzalkonium Chloride, Featured Excipient: Vol. 1 No. 5 336
Assaying Progesterone in Extemporaneously Prepared Suppositories Vol. 1 No. 5 339
Paper-Folding Techniques for Compounded, Individualized Powder Dosage Forms Vol. 1 No. 5 340
Calculations Vol. 1 No. 5 343
Maintenance of Horizontal Laminar Airflow Hood Vol. 1 No. 5 344
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids Vol. 1 No. 5 347
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms Vol. 1 No. 5 349
The Stability of Lisinopril as an Extemporaneous Syrup Vol. 1 No. 5 352
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection Vol. 1 No. 5 354
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions Vol. 1 No. 5 356
PostScription: Should Just Any Pharmacist Compound? Vol. 1 No. 5 362
Ambulatory Care and the Compounding Pharmacist Vol. 1 No. 6 374
Ambulatory Care Medicine: Definition and Scope of Service Vol. 1 No. 6 377
Compounding for Diabetic Patients:An Interview with Paul Lofholm, PharmD Vol. 1 No. 6 381
Compounding Pharmacists Play a Vital Role in AIDS Treatment Vol. 1 No. 6 386
Treating Patients with Asthma Vol. 1 No. 6 389
Antique Suppository Making Tools Vol. 1 No. 6 392
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 1.Statistics for Continuous Data and Stability Studies Vol. 1 No. 6 395
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Vol. 1 No. 6 399
Acyclovir Lip Balm Vol. 1 No. 6 405
Acyclovir Stick with Sunscreen Vol. 1 No. 6 406
Aspirin in Chloroform (Chloroform Banned in US) Vol. 1 No. 6 407
Bismuth Iodoform Paraffin Paste (BIPP) Vol. 1 No. 6 408
Curcumin Ointment Vol. 1 No. 6 409
Dexamethasone and Lidocaine Solution for Iontophoresis Vol. 1 No. 6 410
Estriol Solution for Iontophoresis for Acne Scars Vol. 1 No. 6 411
Fluconazole 200-mg Suppositories Vol. 1 No. 6 412
Fluconazole 2% Shampoo Vol. 1 No. 6 413
Ketoconazole 20-mg/mL Oral Liquid Vol. 1 No. 6 414
Ketorolac Solution for Iontophoresis Vol. 1 No. 6 415
Lidocaine HCl 2% Solution for Iontophoresis Vol. 1 No. 6 416
Morphine 10-mg Troches Vol. 1 No. 6 417
Vancomycin Gel (Vancomycin Paste, Vanc Paste) Vol. 1 No. 6 418
Wound Care Mixture Vol. 1 No. 6 419
Iontophoresis Devices: Clinical Applications for Topical Delivery Vol. 1 No. 6 420
Calculations Vol. 1 No. 6 425
Water, Featured Excipient: Vol. 1 No. 6 426
Laudanum and Paregoric: History and Compounding Considerations Vol. 1 No. 6 428
Origin of Laudanum and Paregoric Vol. 1 No. 6 428
Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps Vol. 1 No. 6 430
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes Vol. 1 No. 6 433
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection Vol. 1 No. 6 435
Short-Term Stability of Atenolol in Oral Liquid Formulations Vol. 1 No. 6 437
Stability of Clonazepam Suspension in HSC Vehicle Vol. 1 No. 6 440
PostScription: Issues for TPN Pharmacists Vol. 1 No. 6 444